Republished: Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection

Knowledge of the immunological events necessary to control hepatitis B virus (HBV) infection has accelerated in recent years, but their translation towards therapeutic strategies able to achieve a durable HBV suppression has been challenging. The scenario of how HBV deals with the host immunity is presented and used to discuss how the immune response can be harnessed to potentially achieve infection control.

[1]  N. King,et al.  IL‐22 and non‐ELR‐CXC chemokine expression in chronic hepatitis B virus‐infected liver , 2012, Immunology and cell biology.

[2]  M. Cobleigh,et al.  A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus. , 2011, Gastroenterology.

[3]  A. Bertoletti,et al.  Licensing Virus-Specific T Cells to Secrete the Neutrophil Attracting Chemokine CXCL-8 during Hepatitis B Virus Infection , 2011, PloS one.

[4]  E. Endl,et al.  Murine hepatic stellate cells veto CD8 T cell activation by a CD54‐dependent mechanism , 2011, Hepatology.

[5]  A. Bertoletti,et al.  Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines. , 2011, Journal of hepatology.

[6]  T. Luedde,et al.  Interleukin-8 Is Activated in Patients with Chronic Liver Diseases and Associated with Hepatic Macrophage Accumulation in Human Liver Fibrosis , 2011, PloS one.

[7]  A. Lohse,et al.  Hepatitis B virus limits response of human hepatocytes to interferon-α in chimeric mice. , 2011, Gastroenterology.

[8]  A. Bowie,et al.  Innate DNA sensing moves to the nucleus. , 2011, Cell host & microbe.

[9]  B. Chandran,et al.  IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated herpesvirus infection. , 2011, Cell host & microbe.

[10]  M. Maini,et al.  Role of the coinhibitory receptor cytotoxic T lymphocyte antigen‐4 on apoptosis‐Prone CD8 T cells in persistent hepatitis B virus infection , 2011, Hepatology.

[11]  H. Marshall,et al.  Virus-Induced Transient Immune Suppression and the Inhibition of T Cell Proliferation by Type I Interferon , 2011, Journal of Virology.

[12]  Shruti Sharma,et al.  Innate Immune Sensing of DNA , 2011, PLoS pathogens.

[13]  R. Lanford,et al.  100 THERAPEUTIC EFFICACY OF THE TLR7 AGONIST GS-9620 FOR HBV CHRONIC INFECTION IN CHIMPANZEES , 2011 .

[14]  W. Leonard,et al.  IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B. , 2011, The Journal of clinical investigation.

[15]  B. Tennant,et al.  1114 ANTI-VIRAL EFFICACY AND INDUCTION OF AN ANTIBODY RESPONSE AGAINST SURFACE ANTIGEN WITH THE TLR7 AGONIST GS-9620 IN THE WOODCHUCK MODEL OF CHRONIC HBV INFECTION , 2011 .

[16]  I. N. Crispe,et al.  Liver antigen-presenting cells. , 2011, Journal of hepatology.

[17]  Jiyuan Zhang,et al.  Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients , 2011, Hepatology.

[18]  P. MacAry,et al.  Targeting Hepatitis B Virus-Infected Cells with a T-Cell Receptor-Like Antibody , 2010, Journal of Virology.

[19]  D. Vergani,et al.  Immune and Viral Profile from Tolerance to Hepatitis B Surface Antigen Clearance: a Longitudinal Study of Vertically Hepatitis B Virus-Infected Children on Combined Therapy , 2010, Journal of Virology.

[20]  M. Maini,et al.  Blockade of Immunosuppressive Cytokines Restores NK Cell Antiviral Function in Chronic Hepatitis B Virus Infection , 2010, PLoS pathogens.

[21]  J. Haas,et al.  The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus‐specific CD8+ T‐cell function , 2010, Hepatology.

[22]  J. Qin,et al.  Hepatitis B Virus Regulatory HBx Protein Binds to Adaptor Protein IPS-1 and Inhibits the Activation of Beta Interferon , 2010, Journal of Virology.

[23]  Y. Li,et al.  Hepatitis B virus X protein suppresses virus-triggered IRF3 activation and IFN-β induction by disrupting the VISA-associated complex , 2010, Cellular and Molecular Immunology.

[24]  K. Fink,et al.  Contribution of Herpesvirus Specific CD8 T Cells to Anti-Viral T Cell Response in Humans , 2010, PLoS pathogens.

[25]  N. Kato,et al.  Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3. , 2010, The Journal of general virology.

[26]  M. Ostrowski,et al.  Comparison of Immune Restoration in Early versus Late Alpha Interferon Therapy against Hepatitis C Virus , 2010, Journal of Virology.

[27]  W. Ryu,et al.  Hepatitis B Virus Polymerase Blocks Pattern Recognition Receptor Signaling via Interaction with DDX3: Implications for Immune Evasion , 2010, PLoS pathogens.

[28]  Youliang Wang,et al.  The Hepatitis B Virus X Protein Disrupts Innate Immunity by Downregulating Mitochondrial Antiviral Signaling Protein , 2010, The Journal of Immunology.

[29]  E. Shevach.  TGF-Beta to the rescue. , 2010, Immunity.

[30]  Hans-Gustaf Ljunggren,et al.  Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection. , 2010, Gastroenterology.

[31]  Antonio Bertoletti,et al.  The Host–pathogen Interaction during HBV Infection: Immunological Controversies , 2010, Antiviral therapy.

[32]  M. Maini,et al.  The molecular basis of the failed immune response in chronic HBV: therapeutic implications. , 2010, Journal of hepatology.

[33]  Antonio Bertoletti,et al.  A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B. , 2010, Journal of hepatology.

[34]  W. Paul,et al.  Mechanisms Underlying Lineage Commitment and Plasticity of Helper CD4+ T Cells , 2010, Science.

[35]  M. Massari,et al.  Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B. , 2010, Gastroenterology.

[36]  J. Flint,et al.  Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties , 2010, Proceedings of the National Academy of Sciences.

[37]  F. Zoulim,et al.  Control of hepatitis B virus replication by innate response of HepaRG cells , 2010, Hepatology.

[38]  Jiyuan Zhang,et al.  Interleukin‐17–producing CD4+ T cells increase with severity of liver damage in patients with chronic hepatitis B , 2010, Hepatology.

[39]  F. Chisari,et al.  Immune effectors required for hepatitis B virus clearance , 2009, Proceedings of the National Academy of Sciences.

[40]  F. Zoulim,et al.  Innate response to hepatitis B virus infection: Observations challenging the concept of a stealth virus , 2009, Hepatology.

[41]  Hildegard Büning,et al.  Not interferon, but interleukin‐6 controls early gene expression in hepatitis B virus infection , 2009, Hepatology.

[42]  M. Mancini-Bourgine,et al.  Hepatitis B virus as a gene delivery vector activating foreign antigenic T cell response that abrogates viral expression in mouse models , 2009, Hepatology.

[43]  P. Klenerman,et al.  Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. , 2009, Gastroenterology.

[44]  A. Bertoletti,et al.  Therapeutic vaccination and novel strategies to treat chronic HBV infection , 2009, Expert review of gastroenterology & hepatology.

[45]  G. Michelone,et al.  Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. , 2009, Gastroenterology.

[46]  Pratip K. Chattopadhyay,et al.  The Size of the Viral Inoculum Contributes to the Outcome of Hepatitis B Virus Infection , 2009, Journal of Virology.

[47]  S. Rosenberg,et al.  Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. , 2009, Blood.

[48]  R. Bartenschlager,et al.  Hepatitis B and C virus coinfection: A novel model system reveals the absence of direct viral interference , 2009, Hepatology.

[49]  E. Shevach.  Mechanisms of foxp3+ T regulatory cell-mediated suppression. , 2009, Immunity.

[50]  T. Watts,et al.  Immune regulation by 4‐1BB and 4‐1BBL: complexities and challenges , 2009, Immunological reviews.

[51]  C. Walker,et al.  Efficacy of hepatitis B vaccine against antiviral drug‐resistant hepatitis B virus mutants in the chimpanzee model , 2009, Hepatology.

[52]  Dongliang Yang,et al.  Hepatitis B virus suppresses toll‐like receptor–mediated innate immune responses in murine parenchymal and nonparenchymal liver cells , 2009, Hepatology.

[53]  M. Massari,et al.  Early kinetics of innate and adaptive immune responses during hepatitis B virus infection , 2009, Gut.

[54]  A. Osterhaus,et al.  In vitro use of autologous dendritic cells improves detection of T cell responses to hepatitis B virus (HBV) antigens , 2009, Journal of medical virology.

[55]  Mila Lebedeva,et al.  Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections , 2009, Journal of Virology.

[56]  L. Frelin,et al.  A Mechanism To Explain the Selection of the Hepatitis e Antigen-Negative Mutant during Chronic Hepatitis B Virus Infection , 2008, Journal of Virology.

[57]  Jinhong Chang,et al.  Activation of Pattern Recognition Receptor-Mediated Innate Immunity Inhibits the Replication of Hepatitis B Virus in Human Hepatocyte-Derived Cells , 2008, Journal of Virology.

[58]  G. Alexander,et al.  Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection , 2008, The Journal of experimental medicine.

[59]  N. D. Churchill,et al.  Churchill and Tomasz I. Michalak Hepadnavirus during Acute Infection with Woodchuck Responses Immediately after Invasion and with Innate and Adaptive Immune Intrahepatic Expression of Genes Affiliated , 2022 .

[60]  Edward J Oakeley,et al.  Interferon signaling and treatment outcome in chronic hepatitis C , 2008, Proceedings of the National Academy of Sciences.

[61]  P. Kellam,et al.  Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection. , 2008, The Journal of clinical investigation.

[62]  U. Haberkorn,et al.  Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein , 2008, Nature Biotechnology.

[63]  R. Pierce,et al.  TLR-dependent cross talk between human Kupffer cells and NK cells , 2008, The Journal of experimental medicine.

[64]  Xiaonan Zhang,et al.  Hepatitis B virus polymerase inhibits the interferon-inducible MyD88 promoter by blocking nuclear translocation of Stat1. , 2007, The Journal of general virology.

[65]  A. Murphy,et al.  Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. , 2007, Immunity.

[66]  R. Binda,et al.  Induction of Regulatory T-Cells and Interleukin-10-Producing Cells in Non-Responders to Pegylated Interferon-α Therapy for Chronic Hepatitis B , 2007, Antiviral therapy.

[67]  G. Sitia,et al.  HBV pathogenesis in animal models: recent advances on the role of platelets. , 2007, Journal of hepatology.

[68]  P. Borrow,et al.  Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell–mediated liver damage , 2007, The Journal of experimental medicine.

[69]  A. Bertoletti,et al.  Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection , 2007, Journal of Virology.

[70]  A. Bertoletti,et al.  The Level of Viral Antigen Presented by Hepatocytes Influences CD8 T-Cell Function , 2007, Journal of Virology.

[71]  S. Lewin,et al.  Regulation of Toll‐like receptor‐2 expression in chronic hepatitis B by the precore protein , 2007, Hepatology.

[72]  S. Müller,et al.  Treatment with HMGB1 inhibitors diminishes CTL‐induced liver disease in HBV transgenic mice , 2007, Journal of leukocyte biology.

[73]  Boping Zhou,et al.  Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B. , 2006, International immunology.

[74]  W. Haining,et al.  Resolution of a chronic viral infection after interleukin-10 receptor blockade , 2006, The Journal of experimental medicine.

[75]  M. Nassal,et al.  Inhibition of Alpha Interferon Signaling by Hepatitis B Virus , 2006, Journal of Virology.

[76]  L. Teyton,et al.  Interleukin-10 determines viral clearance or persistence in vivo , 2006, Nature Medicine.

[77]  Z. Zou,et al.  Circulating and Liver Resident CD4+CD25+ Regulatory T Cells Actively Influence the Antiviral Immune Response and Disease Progression in Patients with Hepatitis B1 , 2006, The Journal of Immunology.

[78]  H. Blum,et al.  Expression of the Interleukin-7 Receptor Alpha Chain (CD127) on Virus-Specific CD8+ T Cells Identifies Functionally and Phenotypically Defined Memory T Cells during Acute Resolving Hepatitis B Virus Infection , 2006, Journal of Virology.

[79]  S. Akira,et al.  Pathogen Recognition and Innate Immunity , 2006, Cell.

[80]  F. Chisari,et al.  Immunobiology and pathogenesis of viral hepatitis. , 2006, Annual review of pathology.

[81]  F. Chisari,et al.  Platelets mediate cytotoxic T lymphocyte–induced liver damage , 2005, Nature Medicine.

[82]  F. Chisari,et al.  Stealth and Cunning: Hepatitis B and Hepatitis C Viruses , 2005, Journal of Virology.

[83]  E. Wherry,et al.  Low CD8 T-Cell Proliferative Potential and High Viral Load Limit the Effectiveness of Therapeutic Vaccination , 2005, Journal of Virology.

[84]  F. Chisari,et al.  Toll-Like Receptor Signaling Inhibits Hepatitis B Virus Replication In Vivo , 2005, Journal of Virology.

[85]  E. Kuipers,et al.  Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection , 2005, Hepatology.

[86]  B. Rehermann,et al.  Immunology of hepatitis B virus and hepatitis C virus infection , 2005, Nature Reviews Immunology.

[87]  E. Wherry,et al.  Antigen-independent memory CD8 T cells do not develop during chronic viral infection. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[88]  G. McCaughan,et al.  The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. , 2004, The Journal of clinical investigation.

[89]  Geoffrey Dusheiko,et al.  Longitudinal Analysis of CD8+ T Cells Specific for Structural and Nonstructural Hepatitis B Virus Proteins in Patients with Chronic Hepatitis B: Implications for Immunotherapy , 2004, Journal of Virology.

[90]  E. Wherry,et al.  Memory CD8 T-Cell Differentiation during Viral Infection , 2004, Journal of Virology.

[91]  F. Chisari,et al.  MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs. , 2004, The Journal of clinical investigation.

[92]  A. Bertoletti,et al.  Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B. , 2003, Journal of hepatology.

[93]  Antonio Bertoletti,et al.  Kinetics of the immune response during HBV and HCV infection , 2003, Hepatology.

[94]  R. Purcell,et al.  CD8+ T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection , 2003, Journal of Virology.

[95]  L. Wodicka,et al.  Genomic analysis of the host response to hepatitis C virus infection , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[96]  Christian Trepo,et al.  Infection of a human hepatoma cell line by hepatitis B virus , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[97]  F. Chisari,et al.  Depletion of neutrophils blocks the recruitment of antigen-nonspecific cells into the liver without affecting the antiviral activity of hepatitis B virus-specific cytotoxic T lymphocytes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[98]  O. Shibolet,et al.  Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers. , 2002, Blood.

[99]  C. Biron,et al.  NK cells and NKT cells in innate defense against viral infections. , 2001, Current opinion in immunology.

[100]  G. Ogg,et al.  Lamivudine treatment can overcome cytotoxic T‐cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy , 2001, Hepatology.

[101]  C. Rogler,et al.  Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus , 2001, Hepatology.

[102]  D. Vergani,et al.  Incubation phase of acute hepatitis B in man: Dynamic of cellular immune mechanisms , 2000, Hepatology.

[103]  Alan S. Perelson,et al.  Kinetics of Acute Hepatitis B Virus Infection in Humans , 2000, The Journal of experimental medicine.

[104]  Antonio Bertoletti,et al.  The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. , 2000 .

[105]  T. Wynn,et al.  An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. , 1999, The Journal of clinical investigation.

[106]  Tomasz P. Michalak,et al.  Persistence of infectious hepadnavirus in the offspring of woodchuck mothers recovered from viral hepatitis. , 1999, The Journal of clinical investigation.

[107]  M. Shapiro,et al.  Viral clearance without destruction of infected cells during acute HBV infection. , 1999, Science.

[108]  A. Bertoletti,et al.  Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. , 1998, The Journal of clinical investigation.

[109]  R. Liang,et al.  Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation. , 1998, Journal of hepatology.

[110]  C. Rabourdin-Combe,et al.  Hepatocytes induce functional activation of naive CD8+ T lymphocytes but fail to promote survival , 1998, European journal of immunology.

[111]  M. Manns,et al.  Hepatitis B associated liver failure following bone marrow transplantation. , 1997, Journal of hepatology.

[112]  H. Thomas,et al.  Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[113]  F. Chisari.  Regulation of human lymphocyte function by a soluble extract from normal human liver. , 1978, Journal of immunology.

[114]  N. Kato,et al.  Hepatitis B virus polymerase inhibits RIGI-and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK 1 / IKK e and DDX 3 , 2010 .

[115]  F. Zoulim,et al.  Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells. , 2009, The Journal of general virology.

[116]  Y. Jeng,et al.  Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses. , 2009, Gastroenterology.

[117]  S. Urban,et al.  T cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes. , 2008, Gastroenterology.

[118]  Boping Zhou,et al.  Association of CD 4 + CD 25 + Foxp 3 + regulatory T cells with chronic activity and viral clearance in patients with hepatitis , 2007 .

[119]  Xiaonan Zhang,et al.  Hepatitis B virus polymerase inhibits the interferon-inducible MyD 88 promoter by blocking nuclear translocation of Stat 1 , 2007 .

[120]  Roger Williams,et al.  Modulation of the CD8 -T-Cell Response by CD4 CD25 Regulatory T Cells in Patients with Hepatitis B Virus Infection , 2005 .

[121]  R. Purcell,et al.  Genomic analysis of the host response to hepatitis B virus infection. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[122]  R. Purcell,et al.  CD 8 T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection † , 2002 .

[123]  M. Roggendorf,et al.  The woodchuck: an animal model for hepatitis B virus infection in man. , 1995, Intervirology.

[124]  Melinda Fitzgerald,et al.  Immunol. Cell Biol. , 1995 .

[125]  A. Lok,et al.  Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. , 1991 .